Thursday 30 November 2017

Orthopedic braces and supports market expected to reach a value of USD 5.8 billion by 2025 : Grand View Research, inc.

The global orthopedicbraces and supports market is expected to reach a value of USD 5.8 billion by 2025, according to a new report by Grand View Research, Inc. There is a growing demand for orthopedic support systems in order to improve the structural and functional features of skeletal and neuromuscular systems. These kinds of support systems restrict mobility to a particular direction, thereby, assisting the overall movement of a patient.
Osteoporosis is one of the leading causes of musculoskeletal disorders amongst the aging population. This generates the need for orthopedic support systems. Geriatric population plays a vital role in accelerating the demand for the products in the market. This population base exhibits highest incidence of musculoskeletal disorders. Aging leads to significant changes in the skeletal and neuromuscular systems, resulting in weak ligament, arthritis, and Anterior Cruciate Ligament (ACL) tear. Currently, the geriatric population is growing at an unprecedented rate. As a result, the demand for orthopedic braces and supports is expected to grow in the near future.
Rising incidence of sport-related injuries has also become a leading cause for osteoarthritis among athletes. Health conscious people are continuously engaged in fitness-related activities. This might lead to muscle pain, which results in increased demand for braces & supports. Sometimes, athletic activities can also result in knee joint disorder, which facilitates rise in demand for knee braces.
Further Key Findings From the Study Suggest:
·         Knee braces and supports held the largest market share in 2015 as knees are extremely vulnerability to injury at the time of sports-related activities
·         Amongst the end-use segment, orthopedic clinic was the largest revenue contributor in 2015 due to increasing preference for orthopedic consultations for quick check up
·         The Over-the-counter (OTC) segment is anticipated to grow at a lucrative CAGR over the forecast period owing to the fact that the braces and support systems are readily available in the retail stores without a doctor’s prescription
·         North America dominated the market in 2015 owing to rising healthcare spending and high purchasing power associated with this region
·         Asia Pacific is expected to witness attractive growth over the forecast period due to rising geriatric population in China
·         Some of the key companies are Bauerfeind AG; DJO Global, Inc.; Ă–ssur Corporate; Breg, Inc.; DeRoyal Industries, Inc.; Otto Bock Healthcare GmbH; and BSN Medical GmbH.
Browse more reports of this category by Grand View Research:  http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the orthopedic braces & supports market on the basis of product, end use, and region:
Orthopedic Braces & Supports Product Outlook (Revenue, USD Million; 2014 - 2025)
·         Knee Braces & Supports
o    Knee Braces for Osteoarthritis and Ligament Injuries
o    Post-operational Knee Braces
·         Foot and Ankle Braces & Supports
o    Soft Braces
o    Hinged Braces
·         Spinal Orthoses
·         Upper Extremity Braces & Supports
o    Shoulder Supports
o    Wrist & Hand Supports
Orthopedic Braces & Supports End-Use Outlook (Revenue, USD Million; 2014 - 2025)
·         Orthopedic Clinics
·         Over the Counter (OTC)
·         Hospitals
·         Others
Orthopedic Braces & Supports Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    India
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-orthopedic-braces-support-systems-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com



Biochipsanticipated market Expected to reach a value of USD 5.8 billion by 2025 : Grand View Research, Inc.

Global biochipsanticipated market to reach USD 25.84 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of personalized medicine and rapid technological advancements in the biochips market along with high market demand from proteomic and genomic applications is expected to drive market growth. 
Anticipated launch and commercialization of novel products for diagnosis and treatment including laboratory- and non-laboratory-based research are expected to further reinforce growth in demand. Improvements in accuracy, resolution, and preparation procedures for the technology coupled with reduction in costs of associated materials are expected to fuel growth over the forecast period. 
Ongoing developments related to further miniaturization of biochips are expected to enhance their applicability and additional usage for genetic sequencing methodologies, such as cancer genomics. Their usage is also expected to aid reduction in the cost of genome profiling, which is a factor likely to drive demand for the next step of genetic analysis, i.e., protein expression analysis. Consequently, a growth in the number of such protein profiling studies is expected to directly fuel demand for genomic and proteomic labeling techniques through to 2024. 
Browse full report by Grand View Research : http://www.grandviewresearch.com/industry-analysis/biochips-market
Further Key Findings From the Report Suggest:
·         DNA chips form the largest revenue-generating segment of the biochip applications. Major contribution to this share comes from usage in cancer diagnostics/treatment and drug discovery applications. DNA chips accounted for around a third of the global market revenue in 2015. The other notable contributing segments to application of biochips include gene expression, single nucleotide polymorphism genotyping, genomic studies, and agricultural biotechnology.
·         The market is expected to have a high potential for growth as the technology has numerous applications to aid the miniaturization of molecular biology and biochemical & chemical assays. Over time, such miniaturization is expected to benefit medical technologies in terms of cost and input requirements.
·         DNA chips, lab-on-a-chip, protein chips, and tissue & cell arrays find a number of uses in pharmaceutical & biotechnology companies, academic & research institutes, hospitals & diagnostic centers, and other end users like point-of-care settings, forensic labs, blood banks, etc.
·         North America was the largest revenue-generating region and accounted for over 45%of total revenue in 2015. This can be attributed to by the presence of government initiatives for personalized patient care coupled with the availability of a very large installed base of genetic and proteomic profiling platforms across the U.S. High market usage of next-gen sequencing techniques for molecular diagnosis and treatment used with microfluidic techniques also add to the large share. Furthermore, cancer analysis projects in a number of academic and clinical research institutes are also responsible for the region’s large share.
·         Some key players operating in this industry include Abbott Laboratories; PerkinElmer, Inc.; GE Healthcare; Illumina, Inc.; Thermo Fisher Scientific, Inc.; Merck Millipore; Agilent Technologies, Inc.; Sigma-Aldrich Corporation; Fluidigm Corporation; and Bio-Rad Laboratories, Inc. 
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the Biochip market on the basis of type, end use, region:
Biochip Outlook, by Type (Revenue, USD Million, 2013 - 2024)
·         DNA chips, by application
o    Cancer diagnosis and treatment
o    Gene expression
o    Single Nucleotide Polymorphisms Genotyping
o    Genomics.
o    Drug discovery
o    Agricultural biotechnology
o     Others
·         Lab-on-a-chip, by application
o    Genomics
o    IVD & POC
o    Proteomics
o    Drug discovery
o     Others
·         Protein chips, by application
o    Proteomics
o    Expression Profiling
o    Diagnostics
o    HTS
o    Drug Discovery
o    Others
·         Tissue Arrays
·         Cell Arrays
Biochip Outlook, by End Use (Revenue, USD Million, 2013 - 2024)
·         Biotechnology and Pharmaceutical Companies
·         Hospitals and Diagnostics Centers
·         Academic & Research Institutes
·         Others
Biochip Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o     UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o     Brazil
·         MEA
o    South Africa
View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-biochip-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Integrated passive devices (IPD) market expected to reach USD 2.64 billion by 2025 : Grand View Research, Inc.

The global integratedpassive devices (IPD) market is expected to reach USD 2.64 billion by 2025, according to a new study by Grand View Research, Inc. The growing demand for wireless, electronic, handheld devices is presumed to drive the market growth over the forecast period.
IPD, such as RF devices, facilitate efficient wireless communication and prevent loss of network signals. They are used across several applications including digital & mixed signals, RF transceivers, power amplifiers, MEMS, digital processors, and power management units. The growing penetration of these devices in wireless consumer market can be attributed to the high volume of customers adopting cellular phones and other IoT devices.
The applications of this technology in digital and mixed signals are fewer, but significant. The commercialization of an application is subject to its potential to comply with electrical performance and density requirements of conventional DC-DC converter modules and high-performance silicon digital interposer substrates.
Additionally, custom-designed IPD used in specialty and niche applications, such as GPS tracking and cellular encryption, are expected to drive the growth of the market. In terms of materials, thin film products are expected to be the next-generation technology benchmarks as they enable higher densities and lower losses. The advancements in sophisticated packaging techniques have resulted in cost-effective IPD and have increased the scope for large-scale commercialization.
Further key findings from the study suggest:
·         The EMS and EMI protection IPD segment dominated the overall market and accounted for over 9% of the market share in 2015. The growth was attributed to its application in wireless medical devices such as stimulators, cardiac pacemakers, and insulin pumps
·         The automotive end-use segment posed as a key segment and accounted for over USD 276 million of the overall industry revenue in 2015. The cost-effectiveness of IPD lead to their usage in automotive electronics applications such as electronic control Unit (ECU), intelligent headlights, and digital speedometers
·         The consumer electronics segment is expected to emerge as the fastest-growing segment with a CAGR of over 13% over the forecasted period, due to the increasing penetration of mobile phones
·         IPDs are presumed to gain traction in the healthcare segment, owing to their use in medical devices, such as pacemakers, enabling size reduction and low power-consumption in the devices
·         The LED lighting segment accounted for over USD 131 million of the overall market in 2015, due to its growing adoption in commercial applications such as billboards, traffic signals, and glow signs. LED lighting consumes low power and facilitates the abovementioned applications
·         The RF IPD segment is expected to significantly contribute to the industry growth and accounted for over USD 806 million of the global industry revenue in 2015, owing to its extensive usage in POS terminals; thereby, contributing toward digital payment facilities
·         The key industry participants include STATS ChipPAC Ltd., ON Semiconductor, IPDiA, STMicroelectronics, Infineon Technologies AG, Amkor Technology, Inc., and TSMC Ltd.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/semiconductors
Grand View Research has segmented the global IPD market based on application, end-use, and region:
IPD Application Outlook (Revenue, USD Million; 2014 - 2025)
·         EMS and EMI protection IPD
·         RF IPD
·         LED lighting
·         Digital &mixed signal IPD
IPD End-use Outlook (Revenue, USD Million; 2014 - 2025)
·         Automobile
·         Consumer electronics
·         Healthcare
·         Others
IPD Regional Outlook (Revenue, USD Million; 2014 - 2025)
·         North America
·         Europe
·         Asia Pacific
·         RoW
View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-integrated-passive-devices-ipd-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

Wax market Expected to reach USD 12.9 billion by 2025 : Grand View Research, Inc.

The global waxmarket is expected to reach USD 12.9 billion by 2025, and is expected to grow at a CAGR of 3.7% from 2017 to 2025, according to a report by Grand View Research, Inc. Rising demand for the product owing to its superior properties including high gloss, non-toxicity, good water repellency and outstanding chemical resistance is anticipated to augment the industry size over the forecast period.
The growing consumption of synthetic wax as it offers various properties such as thermal degradation resistance, high temperature stability and good heat resistance is likely to increase its demand in creams, eye make-ups and lipsticks in cosmetics applications.
Natural wax has been emerging as a potential mineral and synthetic wax alternative on account of its ability to provide luster and excellent oil retention coupled with environment friendly nature. High scuff-resistant toughness and melting point, and chemical stability of the product as a substitute to paraffin, microcrystalline and polyethylene waxes is expected to witness promising gains over the upcoming years.
The candles accounted for 36.01% of the overall revenue share in 2016 and is expected to witness growth owing to high usage of the product are as gift items for various occasions, including house warming gifts, adult birthday party gifts as well as thank you and dinner/hostess party gifts. The increasing demand for blended, palm and soy waxes in candles industry is expected to augment the overall wax consumption in the near future.
Browse full report by Grand View Research : http://www.grandviewresearch.com/industry-analysis/wax-market
Further key findings from the report suggest:
·         Mineral wax is likely to witness significant volume gains with a predicted CAGR of 3.3% from 2017 to 2025 on account of rising consumption of the product in detergents, rubber solutions, aerosol formulation, adhesives, household cleaners, tire manufacturing, and wood treatment applications.
·         North America was the dominant market and accounted for 34.9% of the overall revenue share in 2016. The rising consumption of the product in packaging of milk cartons, paper drinking cups and waxed paper is anticipated to drive the market growth over the forecast period.
·         The cosmetics application is anticipated to augment the U.S. industry consumption as a result of rising demand for various skin-care products such as face masks, creams and peels.The U.S. market has also demonstrated a shift in demand towards natural and organic cosmetics, thereby providing further avenues for growth.  
·         Key players dominating the industry are Evonik Industries AG, ExxonMobil Corp., Sinopec Corp., CNPC, BASF SE, Royal Dutch Shell Plc. And HollyFrontier Corp.
·         Industry is highly competitive with companies undertaking several initiatives including frequent mergers, acquisitions, capital expansion and strategic alliances. Growing plastics and rubber processing sector along with rising consumption of adhesives, fire logs, and candles and decorative products applications is projected to propel the industry demand.
·         In June 2017, BASF SE introduced a new plant for waxes and emollients in Jinshan, Shanghai, China. This plant, having invested over €20 million by the company, was inaugurated on account of further enhancing and complementing BASF’s then current production of primary surfactants, emulsifiers and wax esters, and to serve the personal care industry in China as well as in Asia Pacific.
·         In July 2017, Royal Dutch Shell Plc. introduced new wax products, namely Slackwax 120 and Slackwax 60. These new products will be produced at its manufacturing site in Pulau Bukom, Singapore. By producing over 60,000 tons of these products, the company is aimed at serving its customers in Europe, the U.S. and Asia.
Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/organic-chemicals-and-compounds
Grand View Research has segmented the wax market on the basis of product, application, and region:
Product Outlook (Volume, Tons; Revenue, USD Million; 2014 - 2025)
·         Mineral wax
·         Synthetic Wax
·         Natural Wax
Application Outlook (Volume, Tons; Revenue, USD Million; 2014 - 2025)
·         Candles
·         Packaging
·         Plastic & Rubber
·         Cosmetics & Toiletries
·         Fire Logs
·         Adhesives
Regional Outlook (Volume, Tons; Revenue, USD Million; 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    India
·         Central & South America
o    Brazil
·         Middle East & Africa
View press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-wax-market
About Grand View Research 
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com